Anacetrapib in Heterozygous Familial Hypercholesterolemia | Journal Scan

Study Questions:

What is the safety and efficacy of anacetrapib, a cholesteryl ester transfer protein inhibitor (CETPi), in patients with heterozygous familial hypercholesterolemia (HeFH)?